# Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

> **NCT02242149** · PHASE3 · COMPLETED · sponsor: **Universidade Federal do Rio de Janeiro** · enrollment: 84 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Diacerein
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02242149
- **Lead sponsor:** Universidade Federal do Rio de Janeiro
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-14
- **Primary completion:** 2017-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2018-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242149, "Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02242149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*